ProAssurance to be acquired by The Doctors Company for $25/share cash, ~$1.3B

PROASSURANCE CORP

Stockholders receive $25.00 per share in cash, a ~60% premium to March 18 close.
Transaction valued at approximately $1.3 billion; combined assets ~$12 billion.
ProAssurance board unanimously approved; expected close in first half of 2026.
Closing subject to stockholder approval and regulatory approvals; no financing condition.
Upon close, ProAssurance common stock will be delisted from NYSE.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.